As for gene amplifications, gastric cancers with current and past infection also had similar frequencies of ERBB2 amplification (9% and 3%; p = 0.398) and KRAS amplification (2% and 3%; p = 1.000) (Fig. 3b, Table 3). This evidence concerns the gene ERBB2 and gastric cancer.